All stock lists
Pacific Biosciences Of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
Healthcare · Medical Devices
2.29+0.18 (+8.29%)
Insider Score
––Not scored
PACB Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
PACB analyst forecast
PACB analyst consensus
No analyst ratings in the last 3 months.
PACB 12-month price target
$2.50+11.6% upsideaverage of 1 firm
$2.50High
$2.50Low
Best analysts covering PACB
No firm covering PACB has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PACB analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| Stephens | — | $2.50 | +22.0% | — | 2026-10-23 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.